Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1984-11-06
1986-11-18
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
A61K 3103
Patent
active
046236660
ABSTRACT:
Methods are disclosed for employing diphenylhalonium ion to elicit sodium nitroprusside-like effects in vivo, and to enhance cardiac contractility.
REFERENCES:
patent: 3862333 (1975-01-01), Chalupa et al.
patent: 3885036 (1975-05-01), Moyle et al.
patent: 3981897 (1976-09-01), Crivello
patent: 4151175 (1979-04-01), Crivello et al.
patent: 4173551 (1979-11-01), Crivello
patent: 4216288 (1980-08-01), Crivello
patent: 4234732 (1980-11-01), Crivello
patent: 4238394 (1980-12-01), Crivello et al.
patent: 4264703 (1981-04-01), Crivello
J. Med. Chem. vol. 9, pp. 228-231 (1966)--Wiley et al.
Xenobiotica, 1979, No. 9, 539-546, Some Aspects of the Pharmacology of Diphenyleneiodonium, A Bivalent Iodine Compound.
The Journal of Biological Chemistry, vol. 218, No. 17, Sep. 10, 1974, pp. 6050-6056 Mechanism of Action of the Hypoglycemic Agent Diphenyleneiodonium.
Journal of Animal Science, vol. 46, No. 3, 1977 "Manipulating Rumen Fermentation.
Journal of Animal Science, vol. 49, No. 4, 1979 "Chemical Inhibition of Amino Acid Deamination by Ruminal Microbes in vitro.sup.1,2.
Journal of Cardiovascular Pharmacology 2:247-255, 1980 Raven Press, New York Hypotensive Effects of N,N-Di-n-Propyldopamine in the Anestetized Dog: Comparison with Sodium Nitroprusside.
PBDA in Dog and Man/Fennel et al. Circulation vol. 67, No. 4, Apr. 1983 Propylbutyldopamine: Hemodynamic Effects in Conscious Dogs, Normal Human Volunteers and Patients with Heart Failure.
Medical Intelligence-Cohn and Fraciosa, vol. 297, No. 1, Jul. 7, 1977 "Drug Therapy, Vasodilator Therapy of Cardiac Failure" (Part 1).
Medical Intelligence, The New England Journal of Medicine, Aug. 4, 1977 "Drug Therapy, Vasodilator Therapy of Cardiac Failure (Part 2).
Progress in Cardiovascular Diseases, vol. XXIV, No. 5, Mar./Apr. 1982.
Jul. 1981, The American Journal of Medicine, vol. 71, "Physiologic Basis of Vasodilator Therapy for Heart Failure".
N-Acetylcysteine Potentiates Inhibition of Platelet Aggregation by Nitroglycerin--J. Loscaizo vol. 76, pp. 703-708--Aug. 1985.
A Structurally Novel Stimulator of Guanylate Cyclase with Long-Lasting Hypotensive Activity in the Dog--D. Pettibone et al. European Journal of Pharmacology 116 (1985) 307-312.
P. 1694 from Webster's Third New International Dictionary (1976).
Excerpt from Gould Medical Dictionary.
LandOfFree
Pharmacological applications of diphenylhalonium ion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological applications of diphenylhalonium ion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological applications of diphenylhalonium ion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1617964